Examples of using Multiple-dose in English and their translations into Dutch
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Financial
-
Computer
-
Ecclesiastic
-
Official/political
-
Programming
Multiple-dose study: data are restricted to one study.
Steady-state is attained following 7 to 10 days of multiple-dose administration.
After multiple-dose administration, steady state conditions of selexipag
The renal clearance of methylnaltrexone was reduced following multiple-dose administration of cimetidine from 31 l/ h to 18 L/ h.
In acute and multiple-dose studies, the combination of loratadine/ pseudoephedrine sulfate exhibited a low order of toxicity.
The apparent elimination half-life estimated from the multiple-dose pharmacokinetics with daily dosing was approximately 17 hours.
are linear with accumulation(6-fold) predictable from single- to multiple-dose data.
The single- and multiple-dose pharmacokinetics of telbivudine were evaluated in healthy subjects
No pharmacokinetic interactions were noted between PegIntron and ribavirin in a multiple-dose pharmacokinetic study.
Adults Single-dose and multiple-dose pharmacokinetic studies have been conducted in adult patients undergoing kidney transplantation.
noted between Rebetol and interferon alfa-2b in a multiple-dose pharmacokinetic study.
Co-administration of single-dose bedaquiline and multiple-dose nevirapine did not result in clinically relevant changes in the exposure to bedaquiline.
peginterferon alfa-2b or interferon alfa-2b in a multiple-dose pharmacokinetic study.
In multiple-dose studies, serum concentrations
Lasofoxifene exhibits linear pharmacokinetics over a wide dose range following single-dose(up to 100 mg) and multiple-dose(up to 20 mg once daily) administration.
In an interaction study of single-dose bedaquiline and multiple-dose lopinavir/ritonavir, exposure(AUC)
The pharmacokinetics(PK) of nintedanib can be considered linear with respect to time i.e. single- dose data can be extrapolated to multiple-dose data.
Systemic absorption of all active substances was determined in multiple-dose studies after placing the veterinary medicinal product into both ear canals of healthy mixed breed dogs.
AUC of methylnaltrexone bromide, in addition to Cmax, was observed before and after multiple-dose administration of cimetidine.
In short-term, multiple-dose clinical studies of post-orthopaedic surgical pain
The potential interaction of peginterferon alfa-2b(PegIntron) on substrates of metabolic enzymes was evaluated in 3 multiple-dose clinical pharmacology studies.
In a multiple-dose, dose-ranging study in healthy older adults administered doses ranging from 267 mg to 1,335 mg three times a day,
was observed on the multiple-dose pharmacokinetics of vortioxetine in healthy subjects.
A multiple-dose, open-label study was conducted to evaluate the pharmacokinetics of linagliptin(5 mg dose)
An increase in dose from 750 mg every 8 hours to 1,875 mg every 8 hours in a multiple-dose study resulted in a less than proportional increase(i.e., about 40%) in telaprevir exposure.
In Phase I multiple-dose studies, there were no dose-related clinical adverse reactions observed with sitagliptin with doses of up to 600 mg per day for periods of up to 10 days and 400 mg per day for periods of up to 28 days.
Similar pharmacokinetic parameters were observed in a multiple-dose pharmacokinetic study conducted with the syrup formulation in paediatric poor metaboliser subjects 2- to 11-year old diagnosed with allergic rhinitis.
In the multiple-dose study, steady state was reached after Day 11,
In patients with Parkinson's disease, multiple-dose pharmacokinetics was comparable to single-dose pharmacokinetics,
Multiple-dose study: After repeated doses of 500 mg twice daily for 7 days in paediatric patients the peak plasma concentration(Cmax)